| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
4,420 | 4,992 | 5,793 | 6,784 | 6,967 | 1,417 | 2,175 |
General and administrative | ||||||
5,635 | 3,874 | 4,103 | 8,286 | 4,606 | 1,056 | 256 |
Total operating expenses | ||||||
10,055 | 8,866 | 9,896 | 15,070 | 11,573 | 2,473 | 2,431 |
Loss from operations | ||||||
-10,055 | -8,866 | -9,896 | -15,070 | -11,573 | -2,473 | -2,431 |
Other income (expense): | ||||||
Interest income | ||||||
1,397 | 1,092 | 858 | 452 | 115 | - | - |
Interest income, net (Note 4) | ||||||
- | 0 | 0 | 0 | 11 | 192 | -307 |
Accretion of debt discount (Note 4) | ||||||
- | 0 | 0 | 522 | 423 | 1,324 | 85 |
Change in fair value of derivative (Note 4) | ||||||
- | 0 | 0 | 0 | -135 | -2,633 | 2,284 |
Total other income (expense), net | ||||||
1,397 | 1,092 | 858 | -70 | -432 | -3,765 | 1,892 |
Net loss before income taxes | ||||||
-8,658 | -7,774 | -9,038 | -15,140 | -12,005 | -6,238 | -539 |
Net loss attributable to common stockholders | ||||||
-8,658 | -7,774 | -9,038 | -15,140 | -12,005 | -6,238 | -539 |
Net loss per share, basic and diluted (Note 7) | ||||||
-0.33 | 4,626.73 | -0.39 | -146.02 | -4,484.00 | -1,247,600.00 | - |
Weighted average common shares outstanding used in computing net loss per share, basic and diluted | ||||||
26,042 | 24,818 | 22,907 | 103 | 2 | 0 | - |